Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials

Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trialsMeasuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials, Published online: 29 April 2019; doi:10.1038/s41391-019-0151-4Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials

Source: Prostate Cancer and Prostatic Diseases - April 28, 2019 Category: Urology & Nephrology Authors: Jose Mauricio Mota Andrew J. Armstrong Steven M. Larson Josef J. Fox Michael J. Morris Source Type: research